par Hansen, H H;Eisenhauer, Elizabeth;Hansen, M;Neijt, J P;Piccart-Gebhart, Martine 
;Sessa, C;Thigpen, J T
Référence Annals of oncology, 4 Suppl 4, page (63-70)
Publication Publié, 1993
;Sessa, C;Thigpen, J TRéférence Annals of oncology, 4 Suppl 4, page (63-70)
Publication Publié, 1993
Article révisé par les pairs
| Titre: |
|
| Auteur: | Hansen, H H; Eisenhauer, Elizabeth; Hansen, M; Neijt, J P; Piccart-Gebhart, Martine; Sessa, C; Thigpen, J T |
| Informations sur la publication: | Annals of oncology, 4 Suppl 4, page (63-70) |
| Statut de publication: | Publié, 1993 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antimetabolites, Antineoplastic -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Clinical Trials, Phase II as Topic | |
| Clinical Trials, Phase III as Topic | |
| Deoxycytidine -- analogs & derivatives | |
| Deoxycytidine -- therapeutic use | |
| Female | |
| Humans | |
| Ovarian Neoplasms -- drug therapy | |
| Paclitaxel -- therapeutic use | |
| Randomized Controlled Trials as Topic | |
| Note générale: | Comparative Study |
| Journal Article | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0923-7534 |
| info:pmid/7906138 |
